Travere Therapeutics (TVTX) Reports Confirmatory Data from t

Travere Therapeutics (TVTX) Reports Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI Demonstrating Long-Term Kidney Function Preservation

Travere Therapeutics (TVTX) Reports Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI Demonstrating Long-Term Kidney Function Preservation

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , United States , Brad Rovin , Nivi Nehra , Naomi Eichenbaum , Deric Dube , Travere Therapeutics Inc , Clinical Research Management , Division For Nephrology , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , Ohio State University Center , Exchange Commission , Nasdaq , Corporate Communications , Travere Therapeutics , New Drug Application , Medical Director , Conditional Marketing Authorization , Medicinal Products , Human Use , Important Safety , Endothelin Receptor Antagonists , Upper Limit , Fetal Toxicity , Kidney Injury , Angiotensin System , Acid Reducing Agents , Steroidal Anti Inflammatory Agents , Including Selective , Increasing Serum Potassium , Reproductive Potential , Full Prescribing Information , Private Securities Litigation Reform Act ,